DSM is a global science-based company operating in the fields of Nutrition, Health and Bioscience. Our business is centered around developing innovative solutions and large innovation projects addressing Nutrition & Health, Climate & Energy and Resources & Circularity to drive above market growth.
Key facts and figures about DSM, our broad, global nutrition business and focused, high-quality, specialty materials portfolio and our people, planet & profit performance.
Annual Results published on 15 February confirm DSM delivered a solid financial performance in 2021 and achieved key milestones in its strategic journey.
In 2019 DSM celebrated the 30th anniversary of its privatisation and our ordinary shares being listed on the Euronext Stock Exchange in Amsterdam, the Netherlands.
Our Nutrition cluster comprises DSM Nutritional Products, DSM Food Specialties and DSM Hydrocolloids. This cluster provides solutions for animal precision nutrition and feed, food & beverages, pharmaceuticals, medical nutrition, early life nutrition, nutrition improvement, dietary supplements, personalized nutrition and personal care.
We are active at all stages of the associated value chains, producing pure active ingredients, incorporating them into sophisticated forms and providing tailored premixes, forward solutions and branded consumer products. Our unique portfolio of products and services is global and highly diversified, serving customers and other stakeholders locally across an extensive range of end-markets worldwide.
Our Materials cluster comprises DSM Engineering Materials and DSM Protective Materials. The cluster comprises a high-quality portfolio of specialty materials for global end-markets including electrical components and electronics, automotive, food packaging, medical, personal protection, commercial marine, and apparel. Through our advanced and sustainable solutions, we are meeting demand for safer materials, greater efficiency and improved environmental performance.
Royal DSM, a global purpose-led science-based company, confirmed its resolution to declare a dividend for the financial year 2021 of €2.50 per ordinary share was passed today, 10 May 2022, at its Annual General Meeting of Shareholders.
10 May 2022
Royal DSM, a global purpose-led science-based company, today held its Annual General Meeting of Shareholders. All the resolutions on the agenda were approved by the shareholders.
10 May 2022
Royal DSM, a global purpose-led science-based company, has repurchased 40,085 of its own shares in the period from 2 May 2022 up to and including 6 May 2022 at an average price of €156.08.
10 May 2022
Key facts and figures about DSM, our business and our people, planet & profit performance in one overview.
Instant overview of the financial results, presentations, updates & AGMs and all DSM's financial and regulatory press releases from the last decade.
An introduction to DSM's Investor Relations team and how investors and analysts can contact them.
